Selcia’s 3,000 m3 R+D facility in Ongar (UK) is based across a number of custom designed laboratories that have twice been extended to deal with business growth since the company was established in 2001.
Our laboratories are regularly inspected and licensed by the relevant UK authorities including the Health and Safety Executive (HSE), Medicines and Health products Regulatory Agency (MHRA) and Environment Agency (EA) covering the facility, operations, storage and waste disposal. The facilities have also been subject, over many years, to vigorous quality audits by our global pharmaceutical customers.
We hold a Good Manufacturing Practice (GMP) certificate issued by the UK’s MHRA for the preparation of 14C labelled active pharmaceutical ingredients (APIs) for clinical trials and our analytical laboratory - which supports both our Discovery and Radiolabelling divisions - is GLP MHRA accredited.
Here, analysts experienced in structural biology, structural elucidation and impurity profiling, have access to a comprehensive range of laboratory instrumentation including three high-field NMRs (300MHz, 400MHz and 500MHz) spectrometers, flow and capillary flow LC-NMR, LC-MS/MS and analytical and preparative HPLC.